Practical AI: Adding Insight to the Patient Journey with Digital Phenotyping
In this webinar, Dr. Joseph Zabinski will discuss the digital phenotyping process and several concrete applications to demonstrate how AI can add value to analyses of the patient journey across the life sciences spectrum.
Insights from the 2024 Salary Survey Report by HealthEconomics.com
Keep your finger on the economic pulse of the RWE, HEOR, and Market Access fields. This session focuses on the latest salary and bonus trends for professionals in the field, including a comprehensive overview of the ways industry, job level, location, demographics, and more factor into compensation.
Podcast Q&A: Patient-Centered Real-World Evidence in Rare Diseases
In this episode of tHEORetically Speaking, join Drs. Megan Gower and Edward Chou from Takeda, and Richard Tsai, MS from Inspire, who answer questions from a recent webinar on the challenges and solutions for generating patient-centered real-world evidence (RWE) in the context of rare diseases, to support clinical development through commercial post-approval.
Podcast Q&A: Real-World Evidence Generation with Disease Registries
In this episode of tHEORetically Speaking, join Drs. Javier Cid, Nahila Justo, and Delphine Saragoussi from Evidera and PPD, who answer questions from a recent webinar on why strong connections with registry groups and stakeholder populations are important for generating relevant real-world evidence to advance treatments.
Beyond Accelerated Approvals: External Control Arms
Hear this panel's discussion on the strategic use of external control arms and, if done correctly, how they can help bring products to market in a shorter time and for lower costs.
Delphi Panels: What Are They Good For?
In this webinar, experts deep dive into Delphi panel methods, their implementation, and pharmaceutical industry insights on the panels' use and outcomes.
Patient Voices Matter: Transforming Industry-Sponsored Real-World Evidence with Patient-Centric Approaches
In this webinar, panelists address integrating patient-centered research into real-world studies, focusing on diversity, equity, and inclusion (DEI), and developing systemic approaches for a more equitable research ecosystem.
Integrated Evidence Generation Planning: Driving Successful Reimbursement and Life Cycle Management
Hear four panelists discuss the role of integrated evidence generation in healthcare, focusing on its impact on patient outcomes and healthcare decision-making.
Bridging the Gap: Strategies for Patient-Centered Real-World Evidence in Rare Diseases
Watch this webinar exploring real challenges and solutions for generating patient-centered real-world evidence (RWE) in the context of rare diseases to support clinical development through commercial post-approval.
Partnering with Disease Registries: The Value and Impact for Real-World Evidence Generation
In this webinar, Evidera experts present guidance on why strong connections with registry groups and stakeholder populations are important for generating relevant real-world evidence to advance treatments.
How Cerner Enviza Uses Clinical Data to Drive RWE Decisions
Experts from Cerner Enviza provide a high level overview on utilizing Electronic Health Record (EHR) data to support Real World Evidence (RWE) studies.
Cracking the Code: When and How to Validate ICD Algorithms for RWE
Experts from SickKids, Genentech, Penn Medicine, and PHAR deliver a high level overview on validation of code algorithms for Real World Evidence (RWE)
Optimizing Real-World Evidence for Maternal and Neonatal Outcomes
Experts from health system innovators (C-Path), patients (PreemieWorld), healthcare payers (Carelon Research (formerly HealthCore) & Elevance Health (formerly Anthem)), and industry (Bayer) provide insights into improving neonatal outcomes using RWE.
How Literature Review Automation and Efficient Processes Streamline RWE HEOR Studies
Literature reviews are an essential element in Real World Evidence (RWE) HEOR studies that impact patient care, policy development, and healthcare decision making.
Podcast Q&A: Improving the Representativeness of Research
Dr. Bruce Feinberg, Dr. Danielle Gentile, Dr. Parisa Asgarisabet, and Alexandrina Balanean answer questions on the economic impact and role of real world evidence in improving representativeness of research.
Podcast Q&A: Literature Reviews and Global Value Dossiers
Experts answer questions on systematic literature review issues that can negatively affect your Global Value Dossiers (GVDs) and how automation can improve your product’s market access.
What Every Researcher Needs to Know About Using Medicare Data for Real World Evidence
Join three panelists who provide a practical overview of how and why to use data from Medicare for real world studies.
Medicare Part D: Price Negotiation Panel Discussion
Hear expert panelists bring their perspectives on critical issues around support for Medicare Part D products' fair market prices.
Finding Value in Linking Real-World Data with Social Determinants of Health
Hear Pamela Landsman-Blumberg and Rick Chapman highlight the importance of SDOH and discuss examples of how claims data and EMR linked with SDOH can inform use cases.
Achieving Consensus When Everyone is an Expert, but No One Agrees
Watch experts from PHAR, Novartis, and Bausch Health discuss the Delphi panels and how the results are used.
Cutting Edge Conversations: Addressing Orphan and Rare Diseases
Joseph Zabinski, PhD, MEM, and Jonathan Kish, PhD, MPH, discuss how research groups are working in the realm of orphan and rare diseases.
Using External Control Arm Studies in HTA Submissions: An Alternative, When RCTs are not Feasible
Matthias Hunger, Céline Taveau, and Ankit Pahwa present the challenges and opportunities when using external control arm studies in submissions to HTA agencies.
The Value of a Multi-Source Real-World Data Strategy: How to Overcome Gaps and Limitations
Syapse experts share how to establish high quality, real-world datasets by using a multi-source strategy. A single source of data is often not enough to generate meaningful real-world evidence.
Value-Based Agreements – Are We Going to See More or Less of Them?
Mike Pace, MBA, Pierre Etienne, MD, and Clifton Chow give an insightful and practical webinar on one of the most important areas in pharmaceutical value and market access.
Can Literature Review Automation Improve Healthcare Cost-Effectiveness Analysis and Budget Impact Modeling Outcomes?
Michael Broder, President, PHAR and Jesse Ortendhal, Director of Health Economics, PHAR present on literature review automation in clinic.